Description: Clarus Holdings is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women – including potential therapies for orphan indications. The Company’s first commercial product is JATENZO.
Home Page: clarustherapeutics.com
CRXT Technical Analysis
555 Skokie Boulevard
Northbrook,
IL
60062
United States
Phone:
847 562 4300
Officers
| Name | Title |
|---|---|
| Dr. Robert E. Dudley Ph.D. | Founder, Pres, CEO & Director |
| Mr. Richard Dale Peterson | Chief Financial Officer |
| Mr. Frank A. Jaeger M.A., M.B.A. | Chief Commercial Officer |
| Mr. Steve Stark | VP of Commercial Analytics & Operations |
| Mr. Steven A. Bourne CPA | Chief Admin. Officer, Sec. & Treasurer |
| Ms. Kara J. Stancell | VP of Investor Relations & Corp. Communications |
| Ms. Rozita Passarella | VP of Marketing |
| Mr. Mike Cleveland | VP of Sales |
| Dr. Jay Newmark M.B.A., M.D. | Chief Medical Officer |
| Mr. James Holloway | Sr. VP of Manufacturing & Supply |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.1461 |
| IPO Date: | 2021-09-09 |
| Fiscal Year End: | December |
| Full Time Employees: | 16 |